1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key benefits for the stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Process
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst view
5. GERMANY PROBIOTICS MARKET BY APPLICATION
5.1. Introduction
5.2. Functional Food and Beverages
5.3. Dietary Supplements
5.4. Animal Feed
6. GERMANY PROBIOTICS MARKET BY END-USER
6.1. Introduction
6.2. Human
6.3. Animal
7. GERMANY PROBIOTICS MARKET BY INGREDIENT
7.1. Introduction
7.2. Bacteria
7.2.1. Lactobacilli
7.2.2. Bifidobacterium
7.2.3. Streptococcus thermophilus
7.3. Yeast
7.3.1. Saccharomyces boulardii
7.3.2. Others
8. GERMANY PROBIOTICS MARKET BY FUNCTION
8.1. Introduction
8.2. Regular
8.3. Preventative Healthcare
8.4. Therapeutic
9. GERMANY PROBIOTICS MARKET BY TYPE
9.1. Introduction
9.2. Lactobacillus
9.3. Streptococcus
9.4. Bifidobacterium
9.5. Spore Formers
9.6. Others
10. GERMANY PROBIOTICS MARKET BY FORM
10.1. Introduction
10.2. Liquid
10.3. Dry
11. GERMANY PROBIOTICS MARKET BY PROVINCE
11.1. Introduction
11.2. Berlin
11.3. Hamberg
11.4. Bavaria
11.5. Others
12. COMPETITIVE ENVIRONMENT AND ANALYSIS
12.1. Major Players and Strategy Analysis
12.2. Emerging Players and Markey Lucrativeness
12.3. Mergers, Acquisitions, Agreements, and Collaborations
12.4. Competitive Dashboard
13. COMPANY PROFILES
13.1. ADM
13.2. Yakult
13.3. Activia (Danone)
13.4. Pepsico
13.5. Ehrmann
13.6. BioGaia
13.7. OMNi-BiOTiC
13.8. SymbioPharm
13.9. Evonik